CE mark Geneseeq Nabs CE Marks for Residual Disease and Cancer Early Detection Tests The MRD assay uses deep sequencing to detect cancer mutations in blood post-surgery and the early detection test involves multiomic analysis of cell-free DNA. Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022 Premium The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments. SeekIn Receives CE-IVD Mark for Leukemia Cancer Mutation Detection Kit The company's PanCanSeek test uses whole-genome sequencing to analyze bone marrow samples from leukemia patients, replacing a variety of more targeted technologies. SeekIn Receives CE-IVD Mark for Cancer Recurrence Monitoring Test The company's SeekInCure pan-cancer assay detects minimal residual disease in patient blood samples and has been validated in hepatocellular carcinoma. Cepheid Nabs CE Mark for Group B Strep Test The PCR-based Xpert Xpress GBS test can help screen pregnant women for Streptococcus infections that can lead to early-onset neonatal sepsis. Oct 19, 2022 Genetika+ Snags CE Mark for Major Depressive Disorder Drug-Matching Test Oct 10, 2022 Thermo Fisher Scientific Obtains CE-IVD Mark for PCR-Based GI Bacteria Panel Oct 10, 2022 Ophiomics Liver Cancer Assay Gets CE-IVD Mark Sep 21, 2022 Roche Obtains CE Mark for Three Tests on New Cobas PCR Instrument Sep 15, 2022 Siemens Healthineers Gains CE Marks for Seasonal Viral Disease Assays Sep 13, 2022 Midge Medical Receives CE Mark for Handheld Isothermal MDx, COVID Test Sep 12, 2022 MagBio Genomics Gets 510(k) Clearance, CE Mark for Viral Sample Collection Tube Sep 8, 2022 Cardior Pharmaceuticals MicroRNA PCR Kit Receives CE Marking Sep 2, 2022 BGI Gets CE-IVD Mark for Thalassemia Test Sep 1, 2022 SkylineDx Gains CE-IVD Mark for Melanoma Metastasis Risk Assay Aug 30, 2022 Thermo Fisher Scientific Obtains CE-IVD Mark for Targeted NGS Oncology Test, Analysis Software Aug 18, 2022 CorDx Gets CE-IVD Marks for Monkeypox Assays Aug 9, 2022 Predicine Receives CE-IVD Mark for Blood and Urine Liquid Biopsy Assay Aug 5, 2022 Hyris Gets CE-IVD Mark for SARS-CoV-2 Cellular Immunity Test Jul 21, 2022 PamGene Gains CE-IVD Registration for Immunotherapy Guidance Tests Jul 20, 2022 DiaCarta Gets CE-IVD Mark for SARS CoV-2, Flu A/B Combo Test Jul 11, 2022 Hologic, Thermo Fisher, Accelerate Diagnostics Products Get CE Marks Jul 7, 2022 BforCure Obtains CE-IVD for Point-of-Care COVID PCR Kit Jul 6, 2022 Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition Jul 6, 2022 Abacus Diagnostica Gets CE Mark for Viral Meningitis, Encephalitis Test Kit Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.